Noah Goodman

Chief Business Officer

Noah Goodman (Chief Business Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $898K of KYMR (10,264 sh across 4 lots, as filed), executed Apr 9.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.2M

shares × price, as filed

Last traded

Jul 1

Filed Jul 2

Median ADV $102.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

KYMR

Kymera Therapeutics, Inc. KYMR · 0 buys · 5 sells 5 filings

Recent filings

KYMRSALE Kymera Therapeutics, Inc. View filing → $387K
3,389 sh × $114.29
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $570K
5,000 sh across 2 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $248K
2,500 sh × $99.00
Exec Jun 22
Filed Jun 22 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $121K
1,347 sh × $90.00
Exec Apr 14
Filed Apr 16 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $898K
10,264 sh across 4 lots
Exec Apr 9
Filed Apr 10 · 5:30 PM ET